[at Seeking Alpha] - Thanks, Peg, and good afternoon, everyone. I'm delighted to update you today on the progress we are making with the commercialization and broad clinical development of ADCETRIS and on the advancements ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment